InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: EM post# 6549

Wednesday, 07/11/2018 6:22:26 AM

Wednesday, July 11, 2018 6:22:26 AM

Post# of 8449
The combination is patented - the drug is generic!

If this was so attractive - why market did not care about approval?

When you have generic product available, the marketing expense are going to be huge so no pharma wants to spend that kind of money.

The only possibility is some Israeli co like TEVA or RDHL may show interest but will pay low royalty

I am here because I am in loss and want to get out at least at no loss